Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

Sedation for Brain Magnetic Resonance Imaging in Preterm Infants: Using Propofol under Anesthesiologist Supervision

  • Han, Yea Seul (Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital) ;
  • Kim, Hyun Ho (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hye Seon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Mi Sun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ahn, So Yoon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sung, Se In (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chang, Yun Sil (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Won Soon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2020.04.22
  • Accepted : 2020.06.27
  • Published : 2020.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We aimed to compare two different sedation protocols for brain magnetic resonance imaging (MRI) in preterm infants. One protocol used chloral hydrate (CH) with monitoring conducted by non-anesthesiologists, and the other used a continuous infusion of propofol (PF) with monitoring by anesthesiologists. Methods: A total of 250 preterm infants born between January 2011 and December 2015 who received brain MRI during hospitalization in our neonatal intensive care unit (NICU) were included in this retrospective study. In period 1, sedation for brain MRI was done using a single dose or multiple doses of CH with monitoring conducted by NICU medical staff. In period 2, an anesthesiologist prescribed a continuous infusion of PF and titrated the dosage for minimal and adequate sedation. Data on the adverse events, including desaturation and bradycardia, were collected and compared between periods 1 and 2. Results: Despite similar gestational ages of the patients in periods 1 and 2, the infants in period 1 showed a higher risk of developing bradycardia after sedation compared to those in period 2 (30.2% vs. 14.8%; an adjusted odds ratio of 2.35; 95% confidence interval of 1.12 to 4.91). Infants who had an adverse event after sedation had a lower gestational age and corrected age at the time of MRI (26.8 weeks vs. 27.9 weeks, P=0.004; 37.3 weeks vs. 38.3 weeks, P=0.023). The duration of MRI was significantly longer in infants that had an adverse event than those that did not (70.9 minutes vs. 64.3 minutes). After adjusting for various clinical factors, lower gestational age, lower corrected age at the time of MRI, and period 1 increased the risk of developing adverse events after sedation for MRI. Conclusion: The use of a continuous PF infusion with dose titration and monitoring by an anesthesiologist is safe and feasible as a sedation protocol for brain MRI in prematurely born infants.

Keywords

References

  1. Slaughter LA, Bonfante-Mejia E, Hintz SR, Dvorchik I, Parikh NA. Early conventional MRI for prediction of neurodevelopmental impairment in extremely-low-birth-weight infants. Neonatology 2016;110:47-54. https://doi.org/10.1159/000444179
  2. Pennock JM. Patient preparation, safety and hazards in imaging infants and children. In: Rutherford M, editor. MRI of the neonatal brain. London: W.B. Saunders, 2002:3-15.
  3. Hall RW, Shbarou RM. Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol 2009;36:15-26. https://doi.org/10.1016/j.clp.2008.09.007
  4. Litman RS, Soin K, Salam A. Chloral hydrate sedation in term and preterm infants: an analysis of efficacy and complications. Anesth Analg 2010;110:739-46. https://doi.org/10.1213/ane.0b013e3181ca12a8
  5. Finnemore A, Toulmin H, Merchant N, Arichi T, Tusor N, Cox D, et al. Chloral hydrate sedation for magnetic resonance imaging in newborn infants. Paediatr Anaesth 2014;24:190-5. https://doi.org/10.1111/pan.12264
  6. Pershad J, Palmisano P, Nichols M. Chloral hydrate: the good and the bad. Pediatr Emerg Care 1999;15:432-5. https://doi.org/10.1097/00006565-199912000-00018
  7. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR, Wolf AR. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002;97:1393-400. https://doi.org/10.1097/00000542-200212000-00010
  8. Machata AM, Willschke H, Kabon B, Kettner SC, Marhofer P. Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging. Br J Anaesth 2008;101:239-43. https://doi.org/10.1093/bja/aen153
  9. Pershad J, Wan J, Anghelescu DL. Comparison of propofol with pentobarbital/midazolam/fentanyl sedation for magnetic resonance imaging of the brain in children. Pediatrics 2007;120:e629-36. https://doi.org/10.1542/peds.2006-3108
  10. Arthurs OJ, Sury M. Anaesthesia or sedation for paediatric MRI: advantages and disadvantages. Curr Opin Anaesthesiol 2013;26:489-94. https://doi.org/10.1097/ACO.0b013e3283620121
  11. Allegaert K, Daniels H, Naulaers G, Tibboel D, Devlieger H. Pharmacodynamics of chloral hydrate in former preterm infants. Eur J Pediatr 2005;164:403-7. https://doi.org/10.1007/s00431-005-1648-5
  12. Smallman B. Pediatric sedation: can it be safely performed by non-anesthesiologists? Curr Opin Anaesthesiol 2002;15:455-9. https://doi.org/10.1097/00001503-200208000-00008
  13. Chiaretti A, Benini F, Pierri F, Vecchiato K, Ronfani L, Agosto C, et al. Safety and efficacy of propofol administered by paediatricians during procedural sedation in children. Acta Paediatr 2014;103:182-7. https://doi.org/10.1111/apa.12472
  14. Krauss BS, Krauss BA, Green SM. Procedural sedation and analgesia in children. N Engl J Med 2014;371:91. https://doi.org/10.1056/NEJMc1404371
  15. Cook-Sather SD, Litman RS. Modern fasting guidelines in children. Best Pract Res Clin Anaesthesiol 2006;20:471-81. https://doi.org/10.1016/j.bpa.2006.02.003
  16. Choi YS, Son YJ, Song ES, Cho YK, Kim YO, Kim CJ, et al. Effect of chloral hydrate used for pediatric sedation. J Korean Child Neurol Soc 2008;16:78-85.
  17. Delgado J, Toro R, Rascovsky S, Arango A, Angel GJ, Calvo V, et al. Chloral hydrate in pediatric magnetic resonance imaging: evaluation of a 10-year sedation experience administered by radiologists. Pediatr Radiol 2015;45:108-14. https://doi.org/10.1007/s00247-014-3091-0
  18. Allegaert K. The clinical pharmacology of short acting analgosedatives in neonates. Curr Clin Pharmacol 2011;6:222-6. https://doi.org/10.2174/157488411798375912
  19. Welzing L, Kribs A, Eifinger F, Huenseler C, Oberthuer A, Roth B. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth 2010;20:605-11. https://doi.org/10.1111/j.1460-9592.2010.03330.x
  20. Dalal PG, Murray D, Cox T, McAllister J, Snider R. Sedation and anesthesia protocols used for magnetic resonance imaging studies in infants: provider and pharmacologic considerations. Anesth Analg 2006;103:863-8. https://doi.org/10.1213/01.ane.0000237311.15294.0e
  21. Cravero JP, Blike GT, Beach M, Gallagher SM, Hertzog JH, Havidich JE, et al. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: report from the pediatric sedation research consortium. Pediatrics 2006;118:1087-96. https://doi.org/10.1542/peds.2006-0313
  22. Allegaert K, Peeters MY, Verbesselt R, Tibboel D, Naulaers G, de Hoon JN, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007;99:864-70. https://doi.org/10.1093/bja/aem294
  23. Havidich JE, Beach M, Dierdorf SF, Onega T, Suresh G, Cravero JP. Preterm versus term children: analysis of sedation/anesthesia adverse events and longitudinal risk. Pediatrics 2016;137:e20150463. https://doi.org/10.1542/peds.2015-0463